FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
Go back to FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 49.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.12 | 52 Week High | $35.13 | |||
| Open | $49.12 | 52 Week Low | $28.10 | |||
| Day High | $49.12 | P/E | N/A | |||
| Day Low | $49.12 | EPS | $0.00 | |||
| Volume | 1,305 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 325.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $325.09 | 52 Week High | $195.93 | |||
| Open | $325.09 | 52 Week Low | $155.79 | |||
| Day High | $325.09 | P/E | 60.54 | |||
| Day Low | $325.09 | EPS | $5.37 | |||
| Volume | 952 | |||||
